Senior insider sale
EVP, Chief Technology Officer at HAEMONETICS CORP — senior position signals high conviction
$565.7K
6.24K shares
What this filing means
LINGAMNENI ANILA plans to sell 6.24K shares of HAEMONETICS CORP valued at approximately $565.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/12/2024ACC: 0001959173-24-007707
Officer· EVP, Chief Technology Officer
Since Apr 2020
6.24K
Shares to sell
$565.7K
Approx. market value
6.24K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months8
Option Granted- 05/18/2021
Cash
11/11/2024
2.55KRestricted Stock Vesting
Compensation
5/18/2024
838.00Restricted Stock Vesting
Compensation
5/16/2024
767.00Restricted Stock Vesting
Compensation
5/15/2024
784.00ESPP Purchase
Cash
4/30/2024
289.00Restricted Stock Vesting
Compensation
4/15/2024
362.00ESPP Purchase
Cash
4/28/2023
297.00ESPP Purchase
Cash
4/29/2022
353.00Total acquired6.24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/11/2024 | Option Granted- 05/18/2021 Cash | 2.55K | — |
5/18/2024 | Restricted Stock Vesting Compensation | 838.00 | — |
5/16/2024 | Restricted Stock Vesting Compensation | 767.00 | — |
5/15/2024 | Restricted Stock Vesting Compensation | 784.00 | — |
4/30/2024 | ESPP Purchase Cash | 289.00 | — |
4/15/2024 | Restricted Stock Vesting Compensation | 362.00 | — |
4/28/2023 | ESPP Purchase Cash | 297.00 | — |
4/29/2022 | ESPP Purchase Cash | 353.00 | — |
| Total | 6.24K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
6.24K
Market value
$565.7K
11/11/2024
Total
Units
6.24K
Value
$565.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/11/2024 | 6.24K | $565.7K | NYSE | Planned |
| Total | 6.24K | $565.7K | ||